Plazomicin for the treatment of patients with complicated urinary tract infection.
M.W McCarthy
págs. 513-518
An update on tolvaptan for autosomal dominant polycystic kidney disease.
Esteban Poch López de Briñas, José L. Rodas, Luis M. Blasco, A. Molina, J.L. Quintana
págs. 519-534
Update on multikinase inhibitor therapy for differentiated thyroid cancer.
Veena R. Agrawal, G. Jodon, Rao Mushtaq, Daniel W. Bowles
págs. 535-546
Cardiovascular effects of antidiabetic drugs.
A.M.S. Soerensen, B. M. Christensen
págs. 547-560
Renal complications of cancer therapies.
Martin Schanz, A. Schricker, F. Pfister, M.D. Alscher, M. Kimmel
págs. 561-576
New product intros (andexanet alfa, autologous pancreatic islets, condoliase, danoprevir, darvadstrocel, elagolix sodium, macimorelin acetate, patisiran [first-in-class], pegvaliase-pqpz, pemafibrate).
págs. 577-579
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: